InvestorsHub Logo
Followers 47
Posts 4119
Boards Moderated 1
Alias Born 07/13/2001

Re: None

Monday, 05/09/2016 11:47:00 AM

Monday, May 09, 2016 11:47:00 AM

Post# of 345969
Looking at Avid alone in terms of valuation...

Does anyone have a bit of expertise in determining fair market value?

Am I even close to thinking 10x earnings going forward might be a reasonable assumption? I've lost my handle on what earnings may be. Would appreciate help with getting a number more pinned down.

I am also assuming that the pharma side of the business is going to be scaled down considerably in terms of payroll/positions with the emphasis now leaning on AZN collaboration and other IST's. Thus, drastically reducing trial expenses for Peregrine.

I also assume Peregrine will remain debt free and have very limited use of ATM.

So, if we can get a good handle on what Avid earnings might be and valuation based on what we know, we might be looking at PPHM turning a profit of some kind and hopefully a higher stock price down the road. ??


Thoughts?

Jmo
Loofman


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News